Emilia Bulaevsky Zychlinsky
Directeur des opérations chez Exai Bio, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Patrick Arensdorf | M | - |
Exai Bio, Inc.
 Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Elizabeth Ann Hutt Pollard | F | 57 | 9 ans | |
| Babak Alipanahi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Hani Goodarzi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Mike Pellini | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Shaun Rodriguez | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Seema Bhan | F | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Brian E. Ward | M | 71 | 4 ans | |
| Patrick Plewman | M | 58 | 1 ans | |
| Lori F. Rafield | M | 69 | 8 ans | |
| Christopher Lowe | M | 56 | - | |
| Alexander Johnson | M | - | 1 ans | |
| Sarah Schiltz | F | - | 4 ans | |
| John Curnutte | M | 72 | 1 ans | |
| Leone Patterson | F | 61 | 1 ans | |
| Andrew Galligan | M | 67 | 5 ans | |
| James Sulat | M | 73 | 1 ans | |
| David J. Foster | M | 66 | 1 ans | |
| Louis C. Bock | M | 59 | 1 ans | |
| Charles W. Patrick | M | 69 | 5 ans | |
| Adeoye Olukotun | M | 79 | 2 ans | |
| Paul Manners | M | - | - | |
| Jonathan Ruais | M | 47 | 1 ans | |
| William Harrison Hammond | M | - | 1 ans | |
| Mika Newton | M | - | - | |
| Robert Michael Richey | M | 71 | 3 ans | |
| Jean-Frédéric Viret | M | 58 | 2 ans | |
| E. Ralf Schoenbrunner | M | - | - | |
| Kenneth Charles Fang | M | 61 | - | |
| John Sperzel | M | 60 | - | |
| Robert J. Schott | M | - | - | |
| David W. Nikka | M | 69 | 2 ans | |
| Robert L. Wolfert | M | 70 | 1 ans | |
| Alexander Johnson | M | 50 | 1 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 34 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Emilia Bulaevsky Zychlinsky
- Réseau Personnel
